|
|
Article: Cytokine PharmaSciences Announces Retirement of Richard P. Storm, VP, Corporate Development and Founder.
- Article from:
- PR Newswire
- Article date:
- January 7, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
KING OF PRUSSIA, Pa., Jan. 7 /PRNewswire/ -- Cytokine PharmaSciences, Inc. today announced the retirement of Richard P. Storm as Vice President, Corporate Development. Mr. Storm was a founder of the Company in 1992 and its President and Chief Executive Officer until June 2002. Most recently, he was Vice President, Corporate Development. Mr. Storm will remain as a consultant to the Company and retains his position as a member of the Board of Directors.
Denny Willson, president and CEO of Cytokine PharmaSciences, stated: "Richard is a classic entrepreneur. He created a lasting company out of a troubled technology, applying his intellect, his skills and, most ...
Related newspaper, magazine, and journal articles:
|
|
Article: Genmab Licenses MIF Receptor Target From Cytokine ...
PR Newswire;
November 20, 2006 ;
700+ words
... ... FirstCall/ -- Genmab A/S and Cytokine PharmaSciences, Inc. announced today that Genmab ... to the MIF receptor target from Cytokine PharmaSciences. Genmab intends to develop therapeutic ... Willson, president and CEO of Cytokine PharmaSciences, stated: "Genmab is a world ...
|
|